These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 18231102)

  • 1. Coexpression of EphB4 and ephrinB2 in tumour advancement of ovarian cancers.
    Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T
    Br J Cancer; 2008 Feb; 98(4):845-51. PubMed ID: 18231102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers.
    Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T
    Gynecol Oncol; 2009 Jul; 114(1):84-8. PubMed ID: 19356789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of ephrinB2 and EphB4 in tumor advancement of uterine endometrial cancers.
    Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T
    Ann Oncol; 2007 Mar; 18(3):485-90. PubMed ID: 17108150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential transcriptional and protein expression of thyroid-stimulating hormone receptor in ovarian carcinomas.
    Gyftaki R; Liacos C; Politi E; Liontos M; Saltiki K; Papageorgiou T; Thomakos N; Haidopoulos D; Rodolakis A; Alevizaki M; Bamias A; Dimopoulos A
    Int J Gynecol Cancer; 2014 Jun; 24(5):851-6. PubMed ID: 24844218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of EphrinB2 and EphB4 in glioma tissues correlated to the progression of glioma and the prognosis of glioblastoma patients.
    Tu Y; He S; Fu J; Li G; Xu R; Lu H; Deng J
    Clin Transl Oncol; 2012 Mar; 14(3):214-20. PubMed ID: 22374425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of ephrinB2 signaling on proliferation and invasion in glioblastoma multiforme.
    Bhatia S; Bukkapatnam S; Van Court B; Phan A; Oweida A; Gadwa J; Mueller AC; Piper M; Darragh L; Nguyen D; Gilani A; Knitz M; Bickett T; Green A; Venkataraman S; Vibhakar R; Cittelly D; Karam SD
    Mol Carcinog; 2020 Sep; 59(9):1064-1075. PubMed ID: 32567728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor 1 mRNA is a prognostic factor in ovarian carcinoma: determination by kinetic PCR in formalin-fixed paraffin-embedded tissue.
    Darb-Esfahani S; Wirtz RM; Sinn BV; Budczies J; Noske A; Weichert W; Faggad A; Scharff S; Sehouli J; Oskay-Ozcelik G; Zamagni C; De Iaco P; Martoni A; Dietel M; Denkert C
    Endocr Relat Cancer; 2009 Dec; 16(4):1229-39. PubMed ID: 19675076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia upregulates ovarian cancer invasiveness via the binding of HIF-1α to a hypoxia-induced, methylation-free hypoxia response element of S100A4 gene.
    Horiuchi A; Hayashi T; Kikuchi N; Hayashi A; Fuseya C; Shiozawa T; Konishi I
    Int J Cancer; 2012 Oct; 131(8):1755-67. PubMed ID: 22287060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of the EphrinB2-EphB4 ratio in pediatric cerebral arteriovenous malformations is associated with endothelial cell dysfunction in vitro and functions as a novel noninvasive biomarker in patients.
    Fehnel KP; Penn DL; Duggins-Warf M; Gruber M; Pineda S; Sesen J; Moses-Gardner A; Shah N; Driscoll J; Zurakowski D; Orbach DB; Smith ER
    Exp Mol Med; 2020 Apr; 52(4):658-671. PubMed ID: 32286515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EphA8 is a prognostic marker for epithelial ovarian cancer.
    Liu X; Xu Y; Jin Q; Wang W; Zhang S; Wang X; Zhang Y; Xu X; Huang J
    Oncotarget; 2016 Apr; 7(15):20801-9. PubMed ID: 26989075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significance of EphB4 and EphrinB2 expression and survival in head and neck squamous cell carcinoma.
    Yavrouian EJ; Sinha UK; Rice DH; Salam MT; Gill PS; Masood R
    Arch Otolaryngol Head Neck Surg; 2008 Sep; 134(9):985-91. PubMed ID: 18794445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
    Zamora DO; Davies MH; Planck SR; Rosenbaum JT; Powers MR
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2175-82. PubMed ID: 15914639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Musashi-2 is a novel regulator of paclitaxel sensitivity in ovarian cancer cells.
    Lee J; An S; Choi YM; Lee J; Ahn KJ; Lee JH; Kim TJ; An IS; Bae S
    Int J Oncol; 2016 Nov; 49(5):1945-1952. PubMed ID: 27600258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ephrin B2/EphB4 pathway in hepatic stellate cells stimulates Erk-dependent VEGF production and sinusoidal endothelial cell recruitment.
    Das A; Shergill U; Thakur L; Sinha S; Urrutia R; Mukhopadhyay D; Shah VH
    Am J Physiol Gastrointest Liver Physiol; 2010 Jun; 298(6):G908-15. PubMed ID: 20338920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low concentrations of TNF-α promote osteogenic differentiation via activation of the ephrinB2-EphB4 signalling pathway.
    Wang L; Zhang J; Wang C; Qi Y; Du M; Liu W; Yang C; Yang P
    Cell Prolif; 2017 Feb; 50(1):. PubMed ID: 27726217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome.
    Byrne JA; Maleki S; Hardy JR; Gloss BS; Murali R; Scurry JP; Fanayan S; Emmanuel C; Hacker NF; Sutherland RL; Defazio A; O'Brien PM
    BMC Cancer; 2010 Sep; 10():497. PubMed ID: 20846453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the coexisting HER2 gene amplification and novel mutations in the HER2 protein-overexpressed mucinous epithelial ovarian cancer.
    Lin WL; Kuo WH; Chen FL; Lee MY; Ruan A; Tyan YS; Hsu JD; Chiang H; Han CP
    Ann Surg Oncol; 2011 Aug; 18(8):2388-94. PubMed ID: 21347793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CIP2A is overexpressed in human ovarian cancer and regulates cell proliferation and apoptosis.
    Fang Y; Li Z; Wang X; Zhang S
    Tumour Biol; 2012 Dec; 33(6):2299-306. PubMed ID: 22923389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EphrinB2 and EphB4 expression in pterygia: new insights and preliminary results.
    Xue C; Huang Z; Wang J; Dong Y; Zhou X
    Can J Ophthalmol; 2009 Apr; 44(2):185-8. PubMed ID: 19491953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma.
    Kuo KT; Mao TL; Jones S; Veras E; Ayhan A; Wang TL; Glas R; Slamon D; Velculescu VE; Kuman RJ; Shih IeM
    Am J Pathol; 2009 May; 174(5):1597-601. PubMed ID: 19349352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.